monday.com: Valuation, Margins & Growth
monday.com (MNDY) is rated Hold as revenue growth remains strong, but operating leverage is still too thin to support a higher multiple. The stock looks reasonable on EV/revenue, yet weak…
Read the researchIndependent equity research
Stock research.
The evidence behind the view.
Company analysis, SEC filing changes and public follow-ups. Read the thesis, inspect the assumptions, and see what happened next.
Free research to read now. Premium research is coming.
Latest company analysis
New to LF0?
Three ways to start.
Understand a thesis. Audit a call. Compare a filing.
01 / Read a stock thesis
FormFactor: AI Demand, Customer Concentration & Valuation
FormFactor (FORM) is rated Hold as AI and HBM demand are driving strong growth, but the stock already discounts much of the upside. Rich valuation and customer concentration keep the…
Read the research02 / Check the follow-up
The Scorecard: 1 Month Update: NVTS Sell — Correct so far
Revisiting our Sell call on NVTS: entry $12.34, latest $7.93, -35.7%.
Read the research03 / See what changed
Naploy (NPLY) 2026 10-K Analysis: MD&A Changes
Naploy (NPLY) 2026 10-K analysis comparing the 30 October 2026 filing with its prior-year 10-K, highlighting the MD&A section's biggest changes.
Read the researchFrom the research desk
Find your next read.
Company analysis
monday.com: Valuation, Margins & Growth
monday.com (MNDY) is rated Hold as revenue growth remains strong, but operating leverage is still too thin to support a higher multiple. The stock looks reasonable on EV/revenue, yet weak…
Read the researchCentury Aluminum: Valuation, Cash Flow & Margins
Century Aluminum (CENX) is rated Hold as earnings have improved, but cash conversion remains weak. The stock looks reasonably levered and operationally stronger, yet negative free cash flow keeps the…
Read the researchDeere: Valuation, Free Cash Flow & Debt
Deere & Company (DE) is rated HOLD as its premium valuation already discounts a recovery that is not yet fully visible. Strong free cash flow supports the case, but 6.7x…
Read the researchSEC filing changes
Naploy (NPLY) 2026 10-K Analysis: MD&A Changes
Naploy (NPLY) 2026 10-K analysis comparing the 30 October 2026 filing with its prior-year 10-K, highlighting the MD&A section's biggest changes.
Read the researchRafael Holdings (RFL) 10-K: MD&A Changes Lead 29 October 2026 Filing Roundup
Rafael Holdings (RFL)'s MD&A section changed the most among 6 companies that filed 10-Ks on 29 October 2026, each compared against its prior-year filing.
Read the researchZedge (ZDGE) 10-K: Business Changes Lead 28 October 2026 Filing Roundup
Zedge (ZDGE)'s Business section changed the most among 5 companies that filed 10-Ks on 28 October 2026, each compared against its prior-year filing.
Read the researchCall follow-ups
The Scorecard: 1 Month Update: NVTS Sell — Correct so far
Revisiting our Sell call on NVTS: entry $12.34, latest $7.93, -35.7%.
Read the researchThe Scorecard: 4 Month Update: FTNT Sell — Correct so far
Revisiting our Sell call on FTNT: entry $156.25, latest $136.08, -12.9%.
Read the researchThe Scorecard: 2 Month Update: CUE Sell — Correct so far
Revisiting our Sell call on CUE: entry $26.96, latest $20.87, -22.6%.
Read the researchLF0 Research Desk
Know how the research works.
A rating is a thesis to examine. The original analysis and later scorecard reviews let you see both the reasoning and the outcome.
Stay connected
Like the research?
Be first to hear about premium.
The current research is free to browse. The waitlist is for news about deeper premium analysis when it launches.
This form joins the LF0 premium waitlist. Substack is a separate subscription. You can read the current research without joining either.
Follow your interests
Find a company or sector.
Basic MaterialsCommunication ServicesConsumer CyclicalConsumer DefensiveEnergyFinancial ServicesHealthcareIndustrialsReal EstateTechnologyUtilities
More company research
Explore more of the company analyses featured on LF0.
- Adtran Holdings: ADTN Margins, Cash Flow, Valuation & Turnaround Risk
- Amkor Technology: AMKR Free Cash Flow, Valuation & Customer Concentration
- Clover Health: Valuation & Margins, Cash Flow
- Eos Energy Enterprises: EOSE Cash Burn, Revenue Growth & Financing Risk
- Fluence Energy (FLNC): Backlog vs. Cash Burn
- GeneDx: Valuation, Cash Flow & Margins
- Kimbell Royalty Partners: KRP EBITDA, Leverage, Distribution Risk & Valuation
- NuScale Power: SMR Valuation, Cash Burn, Backlog & Commercialization Risk
- Remitly Global: Valuation, Growth, Margins & Cash Flow